These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38561806)

  • 1. White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition.
    Bachmann D; von Rickenbach B; Buchmann A; Hüllner M; Zuber I; Studer S; Saake A; Rauen K; Gruber E; Nitsch RM; Hock C; Treyer V; Gietl A
    Alzheimers Res Ther; 2024 Apr; 16(1):67. PubMed ID: 38561806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske GM; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Alzheimers Res Ther; 2024 Jul; 16(1):157. PubMed ID: 38987827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Data-Driven White Matter Hyperintensity Spatial Signatures With Distinct Cerebral Small Vessel Disease Etiologies.
    Phuah CL; Chen Y; Strain JF; Yechoor N; Laurido-Soto OJ; Ances BM; Lee JM;
    Neurology; 2022 Dec; 99(23):e2535-e2547. PubMed ID: 36123127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS).
    Eloyan A; Thangarajah M; An N; Borowski BJ; Reddy AL; Aisen P; Dage JL; Foroud T; Ghetti B; Griffin P; Hammers D; Iaccarino L; Jack CR; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Nudelman K; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Rogalski E; Salloway S; Sha S; Turner RS; Wingo TS; Wolk DA; Womack K; Beckett L; Gao S; Carrillo MC; Rabinovici G; Apostolova LG; Dickerson B; Vemuri P;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S89-S97. PubMed ID: 37491599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F; Morrison C; Maranzano J; Zeighami Y; Dadar M
    Geroscience; 2023 Feb; 45(1):1-16. PubMed ID: 36229760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between white matter hyperintensities and amyloid and tau deposition.
    Alban SL; Lynch KM; Ringman JM; Toga AW; Chui HC; Sepehrband F; Choupan J;
    Neuroimage Clin; 2023; 38():103383. PubMed ID: 36965457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral amyloid is associated with greater white-matter hyperintensity accrual in cognitively normal older adults.
    Scott JA; Braskie MN; Tosun D; Maillard P; Thompson PM; Weiner M; DeCarli C; Carmichael OT;
    Neurobiol Aging; 2016 Dec; 48():48-52. PubMed ID: 27639120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Zhang J; Chen H; Wang J; Huang Q; Xu X; Wang W; Xu W; Guan Y; Liu J; Wardlaw JM; Deng Y; Xie F; Li B
    Alzheimers Dement; 2024 Jun; 20(6):3931-3942. PubMed ID: 38648354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
    Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns.
    Pålhaugen L; Sudre CH; Tecelao S; Nakling A; Almdahl IS; Kalheim LF; Cardoso MJ; Johnsen SH; Rongve A; Aarsland D; Bjørnerud A; Selnes P; Fladby T
    J Cereb Blood Flow Metab; 2021 May; 41(5):1162-1174. PubMed ID: 32955960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske G; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Res Sq; 2024 Mar; ():. PubMed ID: 38558965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities.
    Veldsman M; Kindalova P; Husain M; Kosmidis I; Nichols TE
    Neuroimage Clin; 2020; 28():102405. PubMed ID: 32971464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional white matter hyperintensities in posterior cortical atrophy and logopenic progressive aphasia.
    Pham NTT; Graff-Radford J; Machulda MM; Spychalla AJ; Schwarz CG; Senjem ML; Lowe VJ; Vemuri P; Kantarci K; Knopman DS; Petersen RC; Jack CR; Josephs KA; Whitwell JL
    Neurobiol Aging; 2022 Nov; 119():46-55. PubMed ID: 35970009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter hyperintensity topography in Alzheimer's disease and links to cognition.
    Garnier-Crussard A; Bougacha S; Wirth M; Dautricourt S; Sherif S; Landeau B; Gonneaud J; De Flores R; de la Sayette V; Vivien D; Krolak-Salmon P; Chételat G
    Alzheimers Dement; 2022 Mar; 18(3):422-433. PubMed ID: 34322985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.